Skip to content

Neuroplasticity: all studies

Page 83 of 178: studies 821 to 830 of 1,772, newest first. Back to the neuroplasticity overview

Research

The mPFC molecular clock mediates the effects of sleep deprivation on depression-like behavior and regulates sleep consolidation and homeostasis

Molecular Psychiatry March 1, 2026 Wilf Gardner, David H. Sarrazin, Martin Balzinger et al.

Disruptions in sleep, circadian rhythms, and neural plasticity are closely linked to the pathophysiology and treatment of depression. Acute sleep deprivation (SD) produces rapid but transient antidepressant effects, yet the underlying mechanisms remain poorly understood. Using a mouse model of stress-induced depression, we found altered sleep architecture, impaired sleep homeostasis, and...

CONCEPT OF MANAS IN AYURVEDA AND ITS ROLE IN PSYCHOPHYSIOLOGICAL REGULATION: AN INTEGRATIVE REVIEW

International Journal of Research in Ayurveda and Pharmacy February 28, 2026 Rina Arun Jadhav, Manjunatha Adiga

Ayurveda describes health as a state of dynamic balance between Sharira(body), Indriya (Sensory and motor systems), Manas (Mind), and Atma (Conscious self), and places strong emphasis on the role of Manas in both the origin and recovery of disease. Classical texts identify Rajas (Hyperarousal) and Tamas (Hypoarousal) as manasika dosha (mental regulatory patterns) and explain Prajnaparadha...

DOI: 10.7897/2277-4343.17128 (opens in new tab) Mindfulness Psychological intervention Contemplation Cognition +5

Inefficient default mode network hyperconnectivity characterizes chronic low back-related leg pains: a static and dynamic functional MRI study.

Brain Imaging and Behavior February 28, 2026 Ziwei Yang, Xiao Liang, Yuqi Ji et al.

Pain-induced reorganization of the default mode network (DMN) exhibits distinct temporal signatures in the acute and chronic stages, yet the mechanistic interplay between static/dynamic network topology and pain chronicity remains unclear. In this study, we utilized both static and dynamic graph theory analyses to characterize DMN reconfiguration in 50 patients with low back-related leg pain...

Ketamine and Esketamine Therapy in Affective Disorders: A Comprehensive Review of Mechanisms, Clinical Evidence, Safety, and Future Directions

Zenodo (CERN European Organization for Nuclear Research) February 28, 2026 Kshirsagar Pankaj*, Misal Shivdarshan, Dr. Giri Ashok preprint

Major Depressive Disorder (MDD) and Bipolar Depression represent significant global health burdens because about one-third of patients who receive standard monoaminergic antidepressant treatment fail to achieve remission. The population with Treatment-Resistant Depression (TRD) needs assistance because they deal with dangerous suicide risks and struggle with their daily activities. The review...

Understanding Cognitive Neuroscience of Meditation for the Well-being of Humankind: A Comprehensive Review

Journal of medicine and health research February 27, 2026 Amandeep Kaur, P. Gill, Deepinder Kaur

Meditation is a family of self-regulation exercises that train attention and awareness and produce measurable neurobiological adaptations, including increased cortical thickness in the left hippocampus and posterior Cingulate Cortex and enhanced functional connectivity between the prefrontal cortex and the default mode network, which reflects improved emotional regulation and neuroplasticity....

Ketamine pharmacotherapy for major depressive disorder: A narrative review

Progress in Neuro-Psychopharmacology and Biological Psychiatry February 27, 2026 Chris H. Miller, Angela Hickman, Caitlin Baten et al. 2 citations

Ketamine pharmacotherapy provides a novel treatment option for major depressive disorder (MDD) and has generated a large, growing body of research regarding its biochemical and clinical properties. This narrative review summarizes the history of ketamine's development, beginning as a general anesthetic, continuing with a discovery of its antidepressant properties, and leading up to its landmark...

Predictors of the Effectiveness of Psychedelics in Treating Depression—A Scoping Review

International Journal of Molecular Sciences February 26, 2026 James Chmiel, Filip Rybakowski

Psychedelic-assisted therapies (PATs) can produce rapid and sustained antidepressant effects, yet variability in response remains substantial. Identifying predictors and moderators is essential for optimising patient selection, preparation, and delivery. To map and synthesise the evidence on the predictors of antidepressant response to classic/serotonergic psychedelics administered with...

DOI: 10.3390/ijms27052202 (opens in new tab) Comorbidity Antidepressant Psycinfo Medline +5

State-Dependent Remodeling of Astrocytic Proteome and Phosphorylation Signaling Networks Across Wake, Sleep, and General Anesthesia.

International Journal of Molecular Sciences February 25, 2026 Mengchan Su, Qingran Li, Ping Liao et al.

Astrocytes critically regulate states of consciousness, yet their molecular profiles across wake, sleep, and general anesthesia remain unclear. This study conducted proteomic and phosphoproteomic analyses of rat cortical astrocytes across these states using sevoflurane. Data quality was validated using principal component analysis (PCA) and Pearson correlation coefficient (PCC). Proteomics...

DOI: 10.3390/ijms27052159 (opens in new tab) Full text (opens in new tab) Astrocyte Consciousness General anesthesia Phosphoproteomics +1

Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamine

General Hospital Psychiatry February 25, 2026 Alan C. Courtes, Blake Myers, Noah Daly et al. 1 citation

Psychological stress not only undermines quality of life for people with cancer but also fuels tumor growth. Emerging evidence from the nascent field of cancer neuroscience suggests that adrenergic signaling from direct tumor-neuron interactions drives cancer progression, resistance to treatment, and worse outcomes. Cancer neuroscientists are increasingly seeking to repurpose psychoactive...

Increased cortical thickness and decreased brain age among special operations veterans with blast TBI after a magnesium-ibogaine protocol

iScience February 21, 2026 Andrew Geoly, John P. Coetzee, Derrick Matthew Buchanan et al.

= 22). Longitudinal analyses assessed cortical thickness, subcortical volume, and predicted brain age (pBA), estimated from T1 scans. pBA was significantly reduced at 1 month relative to baseline (-1.3 years). Cortical thickness analysis revealed post-treatment increases in 11 regions. Subcortical analyses revealed significant volumetric expansion in 8 regions. Magnesium-ibogaine therapy was...

DOI: 10.1016/j.isci.2026.115121 (opens in new tab) Protocol science Traumatic brain injury Brain aging Neurology +2